# Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

> **NCT02482324** · PHASE1 · COMPLETED · sponsor: **AZTherapies, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ALZT-OP1a
- **DRUG:** ALZT-OP1b
- **DEVICE:** Dry Powder Inhaler

## Key facts

- **NCT ID:** NCT02482324
- **Lead sponsor:** AZTherapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-07-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482324, "Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02482324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*